Weekly Check-In aims to cut cancer treatment delays for black patients

NCT ID NCT06096623

First seen Feb 05, 2026 · Last updated Jun 22, 2026 · Updated 22 times

Summary

This study tests whether a brief weekly survey can help spot when cancer patients are about to experience treatment delays. Researchers will enroll 240 people with newly diagnosed breast or colorectal cancer. Participants answer a short questionnaire each week for 8 weeks. The goal is to see if this tool can flag delays early and help reduce racial disparities in cancer care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of North Carolina

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Weekly electronic patient-reported outcome (ePRO) survey

What this could lead to

If successful, this approach could help care teams identify patients at risk of treatment delays and intervene sooner, potentially reducing disparities.

What could go wrong

This is a small, early feasibility study, not a treatment trial. The survey may not accurately predict delays or lead to meaningful changes in care.

Conditions

The condition(s) this trial relates to.

breast neoplasm colorectal neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.